Erivedge and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported as a side effect among people who take Erivedge (vismodegib), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Alprazolam, and have Basal cell carcinoma.

The phase IV clinical study analyzes which people have Intestinal obstruction when taking Erivedge. It is created by eHealthMe based on reports of 7,786 people who have side effects when taking Erivedge from the FDA, and is updated regularly.

What is Erivedge?

Erivedge has active ingredients of vismodegib. eHealthMe is studying from 7,787 Erivedge users. Check the latest studies of Erivedge.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 1,887 drugs and 2,613 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.

On Jul, 14, 2026

7,786 people reported to have side effects when taking Erivedge.
Among them, 18 people (0.23%) have Intestinal obstruction.

Could Erivedge cause Intestinal obstruction?

Among these 18 people:

How long have people been on Erivedge when they have Intestinal obstruction? *

What is the gender of people who have Intestinal obstruction when taking Erivedge? *

female: 70.59 %
male: 29.41 %

What is the age of people who have Intestinal obstruction when taking Erivedge? *

What are other drugs people take besides Erivedge? *

What are other side effects people have besides Intestinal obstruction? *

Muscle Spasms (muscle contraction): 5 people, 27.78%
Hair Loss: 5 people, 27.78%
Gastric Ulcer (stomach ulcer): 5 people, 27.78%
Dry Skin: 3 people, 16.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 16.67%
Loss Of Consciousness: 2 people, 11.11%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 11.11%
Weight Decreased: 1 person, 5.56%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 5.56%
General Physical Health Deterioration (weak health status): 1 person, 5.56%

What are the existing conditions these people have? *

Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 27.78%
Stress And Anxiety: 5 people, 27.78%
Nasal Cavity Cancer: 5 people, 27.78%
Depression: 5 people, 27.78%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 5 people, 27.78%
Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 2 people, 11.11%
Scrotal Cancer (cancer of scrotum): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Erivedge and have Intestinal obstruction?

- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erivedge:

Erivedge (7,787 reports)

Browse all side effects of Erivedge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (1,887 drugs)

Browse all the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,613 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vismodegib (the active ingredients of Erivedge) and Erivedge (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.